{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:05:34Z","timestamp":1792494334510,"version":"4.5.0"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,5,15]]},"DOI":"10.18632\/aging.204697","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T15:22:04Z","timestamp":1683386524000},"page":"3644-3677","source":"Crossref","is-referenced-by-count":4,"title":["FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma"],"prefix":"10.18632","volume":"15","author":[{"given":"Weilong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoling","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"},{"name":"Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjian","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiannian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"},{"name":"Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-jia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Beijing Chaoyang Hospital West, Capital Medical University, Beijing 100054, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"},{"name":"Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"},{"name":"Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Hematology, Beijing Chaoyang Hospital West, Capital Medical University, Beijing 100054, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"},{"name":"Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"},{"name":"Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Hematology, Biodynamic Optical Imaging Center (BIOPIC) and Lymphoma Research Center, Third Hospital, Peking University, Beijing 100084, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma.","volume":"35","author":"Rajkumar","year":"2004","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma.","volume":"36","author":"Anderson","year":"2011","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41571-018-0018-y","article-title":"The multiple myelomas - current concepts in cytogenetic classification and therapy.","volume":"1","author":"Rajkumar","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3%3c842::aid-cncr2820360303%3e3.0.co;2-u","article-title":"A clinical staging system for multiple myeloma.","volume":"3","author":"Salmon","year":"1975","journal-title":"Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma.","volume":"2","author":"Morgan","year":"2005","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.","volume":"2","author":"Kuehl","year":"2009","journal-title":"Leukemia"},{"key":"7","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.","volume":"3","author":"Attal","year":"2015","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/cncr.31243","article-title":"Current developments in immunotherapy in the treatment of multiple myeloma.","volume":"12","author":"Engelhardt","year":"2018","journal-title":"Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/14656566.2018.1441287","article-title":"Proteasome inhibitors for the treatment of multiple myeloma.","volume":"1","author":"Petrucci","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00335-016-9619-x","article-title":"Exome sequencing identifies a nonsense mutation in Fam46a associated with bone abnormalities in a new mouse model for skeletal dysplasia.","volume":"2","author":"Wolf","year":"2016","journal-title":"Mamm Genome"},{"key":"11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrc3485","article-title":"Translational control of cell growth and malignancy by the CPEBs.","volume":"1","author":"Richter","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.arr.2012.03.004","article-title":"The CPEB-family of proteins, translational control in senescence and cancer.","volume":"1","author":"M\u00e9ndez","year":"2012","journal-title":"Ageing Res Rev"},{"key":"13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.molcel.2006.08.016","article-title":"Opposing polymerase-deadenylase activities regulate cytoplasmic polyadenylation.","volume":"2","author":"Richter","year":"2006","journal-title":"Mol Cell"},{"key":"14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.cell.2004.10.029","article-title":"Symplekin and xGLD-2 are required for CPEB-mediated cytoplasmic polyadenylation.","volume":"11","author":"Richter","year":"2004","journal-title":"Cell"},{"key":"15","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1093\/nar\/gkw222","article-title":"FAM46 proteins are novel eukaryotic non-canonical poly(A) polymerases.","volume":"4","author":"Ginalski","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"16","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.1093\/nar\/gkp854","article-title":"Comprehensive classification of nucleotidyltransferase fold proteins: identification of novel families and their representatives in human.","volume":"3","author":"Ginalski","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41467-017-00578-5","article-title":"The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma.","volume":"8","author":"Dziembowski","year":"2017","journal-title":"Nat Commun"},{"key":"18","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/bjh.13793","article-title":"Compendium of FAM46C gene mutations in plasma cell dyscrasias.","volume":"17","author":"Lionetti","year":"2016","journal-title":"Br J Haematol"},{"key":"19","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1038\/ncomms3997","article-title":"Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.","volume":"5","author":"Tubio","year":"2014","journal-title":"Nat Commun"},{"key":"20","doi-asserted-by":"publisher","first-page":"7776","DOI":"10.1158\/1078-0432.CCR-11-1791","article-title":"Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.","volume":"1","author":"Morgan","year":"2011","journal-title":"Clin Cancer Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"864058","DOI":"10.1155\/2014\/864058","article-title":"The genetic architecture of multiple myeloma.","volume":"201","author":"Chevassut","year":"2014","journal-title":"Adv Hematol"},{"key":"22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1469-1809.2007.00393.x","article-title":"Genetic analysis of FAM46A in Spanish families with autosomal recessive retinitis pigmentosa: characterisation of novel VNTRs.","volume":"7","author":"Anti\u00f1olo","year":"2008","journal-title":"Ann Hum Genet"},{"key":"23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response.","volume":"47","author":"Rice","year":"2011","journal-title":"Nature"},{"key":"24","volume-title":"The molecular cloning and characterization of Fam46c RNA stability factor","author":"Tian","year":"2010"},{"key":"25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/157339471002141124121404","article-title":"Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma.","volume":"1","author":"Ghobrial","year":"2014","journal-title":"Curr Cancer Ther Rev"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Lagali, Kakuk, Griesinger, Wong, Ayyagari. Identification and characterization of C6orf37, a novel candidate human retinal disease gene on chromosome 6q14. Biochem Biophys Res Commun. 2002; 293:356-65. https:\/\/doi.org\/10.1016\/S0006-291X(02)00228-0.","DOI":"10.1016\/S0006-291X(02)00228-0"},{"key":"27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations.","volume":"19","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","article-title":"Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.","volume":"2","author":"Chapman","year":"2014","journal-title":"Cancer Cell"},{"key":"29","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.","volume":"36","author":"Yang","year":"2009","journal-title":"N Engl J Med"},{"key":"30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nature21705","article-title":"Hypersensitive termination of the hypoxic response by a disordered protein switch.","volume":"54","author":"Wright","year":"2017","journal-title":"Nature"},{"key":"31","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/leu.2009.122","article-title":"International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.","volume":"2","author":"Giralt","year":"2009","journal-title":"Leukemia"},{"key":"32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nprot.2014.006","article-title":"Full-length RNA-seq from single cells using Smart-seq2","volume":"9","author":"Sandberg","year":"2014","journal-title":"Nat Protoc"},{"key":"33","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","article-title":"TopHat: discovering splice junctions with RNA-Seq.","volume":"2","author":"Salzberg","year":"2009","journal-title":"Bioinformatics"},{"key":"34","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.","volume":"1","author":"Salzberg","year":"2013","journal-title":"Genome Biol"},{"key":"35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation.","volume":"2","author":"Pachter","year":"2010","journal-title":"Nat Biotechnol"},{"key":"36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.1665","article-title":"The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.","volume":"2","author":"Thomas","year":"2010","journal-title":"Nat Biotechnol"},{"key":"37","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","article-title":"Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib.","volume":"10","author":"Sonneveld","year":"2007","journal-title":"Blood"},{"key":"38","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1182\/blood-2009-12-261032","article-title":"Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients.","volume":"11","author":"Kersten","year":"2010","journal-title":"Blood"},{"key":"39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","article-title":"A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.","volume":"2","author":"Hideshima","year":"2012","journal-title":"Cancer Cell"},{"key":"40","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1182\/blood-2016-06-723007","article-title":"Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.","volume":"12","author":"Molnar","year":"2016","journal-title":"Blood"},{"key":"41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ccr.2012.12.001","article-title":"NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.","volume":"2","author":"Miles","year":"2013","journal-title":"Cancer Cell"},{"key":"42","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa053583","article-title":"Thalidomide and hematopoietic-cell transplantation for multiple myeloma.","volume":"35","author":"Thertulien","year":"2006","journal-title":"N Engl J Med"},{"key":"43","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1182\/blood-2005-10-4084","article-title":"Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies.","volume":"10","author":"Crowley","year":"2006","journal-title":"Blood"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T12:20:48Z","timestamp":1684758048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,5,15]]}},"alternative-id":["204697","37155154"],"URL":"https:\/\/doi.org\/10.18632\/aging.204697","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,6]]}}}